Fred B. Craves, Director at PONIARD PHARMACEUTICALS, INC. (PARD), bought 15,000 shares at $2.15 ($32K) on 2009-03-26, disclosed to the SEC on 2009-03-30.
Open-market purchase of $32k PARD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.05 | 500 | $1K | 3.3% |
| 2 | $2.06 | 1,300 | $3K | 8.5% |
| 3 | $2.07 | 1,300 | $3K | 8.5% |
| 4 | $2.08 | 1,700 | $4K | 11.2% |
| 5 | $2.09 | 1,900 | $4K | 12.6% |
| 6 | $2.10 | 3,400 |
| $7K |
| 22.7% |
| 7 | $2.12 | 1,500 | $3K | 10.1% |
| 8 | $2.13 | 800 | $2K | 5.4% |
| 9 | $2.15 | 2,600 | $6K | 17.7% |
| Total | $2.10 avg | 15,000 | $32K | 100% |
| Filing → |
| MDGL | SELL | 2024-11-27 | $1.2M | — | Filing → |
| MDGL | SELL | 2024-05-16 | $9.3M | — | Filing → |
| MDGL | SELL | 2020-08-19 | $5.2M | — | Filing → |